Proteomic analyses of bioactive molecules in health and disease
Author: Jägerbrink, Theres
Date: 2008-06-13
Location: Samuelssonsalen, Scheelelaboratoriet, Tomtebodavägen 6, Karolinska Institutet
Time: 09.00
Department: Institutionen för medicinsk biokemi och biofysik (MBB) / Department of Medical Biochemistry and Biophysics
View/ Open:
Thesis (907.8Kb)
Abstract
After the mapping of genomes and knowing the blueprints of the possible gene products, focus is shifting from genomics to proteomics. Proteome analyses can be used for diagnosis, prognosis and monitoring of diseases and for characterization of bioactive compounds and their mechanisms of action. Post-translational modifications, as for example phosphorylations, are important for activity of many bioactive molecules.
In paper I, a novel compact disc (CD) based microfluidic method for detection and enrichment of phosphopeptides was tested. Peptides were on-CD processed using immobilized metal affinity chromatography (IMAC), followed by on-CD MALDI mass spectrometry. In about 200 analyses, with a BSA tryptic peptide background, successful detection of phosphopeptides after IMAC enrichment was achieved in 94% of the cases. Applied to the ligand-binding domain of the human mineralocorticoid receptor the method identified two novel phosphorylation sites. 2D-gel electrophoresis (2-DE) is a well established technique in proteomics. Although with limitations, proteome analysis can supply us with important information on biological materials. Comparisons of patterns in 2-DE obtained from normal versus specific disease states can be used to trace marker proteins.
In paper II, a proteome analysis of Vernix caseosa by 2-DE and mass spectrometry gave us insight into the role of vernix; we identified 41 proteins of which 25 were novel to vernix and nearly 40% turned out to have a role in innate immunity. Continuing with 2D-gel separations whole cell extracts from isolated drug-treated and from native pancreatic rat islets were separated by 2-DE in paper III. The silver stained gels were scanned, processed by the image analysis tool PDQuest and 22 differentially expressed proteins were identified by mass spectrometry, 15 up-regulated and 7 down-regulated.
In paper IV, we directly studied molecular interactions of the insulin releasing imidazoline compound (BL11282) from paper III using SPR technology and affinity purification with magnetic beads. We identified two proteins binding to the drug, elongation factor 1 alpha and glucose regulated protein 94.
In patients with chronic kidney disease (CKD), peptides and proteins circulate in elevated concentrations. It is estimated that more than 106 different protein components are circulating in the plasma, but a few abundant proteins contribute to 99% of the protein mass. A multiple affinity removal system was employed in paper V, followed by a workflow including HPLC and SDS-PAGE separation and subsequent protein identification by mass spectrometry. We identified 29 proteins present at altered levels in CKD plasma compared to the amounts in plasma from healthy individuals.
In paper VI, we again study molecular interactions in relation to diabetes. An oxidative cross linking method was optimized and applied to the proinsulin C-peptide. An interaction partner of biological significance (protein tyrosine phosphatase 1B) was identified, and the concept of cross-linking affinity purification, CLAP, was introduced. Proteome analyses include a wide variety of methods. The selection of methods is of great importance for the outcome of proteomic studies, and the need for method development is not expected to cease. In this thesis, a selection of both well established and novel proteomic methods was used to study bioactive molecules.
In paper I, a novel compact disc (CD) based microfluidic method for detection and enrichment of phosphopeptides was tested. Peptides were on-CD processed using immobilized metal affinity chromatography (IMAC), followed by on-CD MALDI mass spectrometry. In about 200 analyses, with a BSA tryptic peptide background, successful detection of phosphopeptides after IMAC enrichment was achieved in 94% of the cases. Applied to the ligand-binding domain of the human mineralocorticoid receptor the method identified two novel phosphorylation sites. 2D-gel electrophoresis (2-DE) is a well established technique in proteomics. Although with limitations, proteome analysis can supply us with important information on biological materials. Comparisons of patterns in 2-DE obtained from normal versus specific disease states can be used to trace marker proteins.
In paper II, a proteome analysis of Vernix caseosa by 2-DE and mass spectrometry gave us insight into the role of vernix; we identified 41 proteins of which 25 were novel to vernix and nearly 40% turned out to have a role in innate immunity. Continuing with 2D-gel separations whole cell extracts from isolated drug-treated and from native pancreatic rat islets were separated by 2-DE in paper III. The silver stained gels were scanned, processed by the image analysis tool PDQuest and 22 differentially expressed proteins were identified by mass spectrometry, 15 up-regulated and 7 down-regulated.
In paper IV, we directly studied molecular interactions of the insulin releasing imidazoline compound (BL11282) from paper III using SPR technology and affinity purification with magnetic beads. We identified two proteins binding to the drug, elongation factor 1 alpha and glucose regulated protein 94.
In patients with chronic kidney disease (CKD), peptides and proteins circulate in elevated concentrations. It is estimated that more than 106 different protein components are circulating in the plasma, but a few abundant proteins contribute to 99% of the protein mass. A multiple affinity removal system was employed in paper V, followed by a workflow including HPLC and SDS-PAGE separation and subsequent protein identification by mass spectrometry. We identified 29 proteins present at altered levels in CKD plasma compared to the amounts in plasma from healthy individuals.
In paper VI, we again study molecular interactions in relation to diabetes. An oxidative cross linking method was optimized and applied to the proinsulin C-peptide. An interaction partner of biological significance (protein tyrosine phosphatase 1B) was identified, and the concept of cross-linking affinity purification, CLAP, was introduced. Proteome analyses include a wide variety of methods. The selection of methods is of great importance for the outcome of proteomic studies, and the need for method development is not expected to cease. In this thesis, a selection of both well established and novel proteomic methods was used to study bioactive molecules.
List of papers:
I. Hirschberg D, Jägerbrink T, Samskog J, Gustafsson M, Ståhlberg M, Alvelius G, Husman B, Carlquist M, Jörnvall H, Bergman T (2004). Detection of phosphorylated peptides in proteomic analyses using microfluidic compact disk technology. Anal Chem. 76(19): 5864-71
Pubmed
II. Tollin M, Jägerbrink T, Haraldsson A, Agerberth B, Jörnvall H (2006). Proteome analysis of vernix caseosa. Pediatr Res. 60(4): 430-4. Epub 2006 Aug 28
Pubmed
III. Jägerbrink T, Lexander H, Palmberg C, Shafqat J, Sharoyko V, Berggren PO, Efendic S, Zaitsev S, Jörnvall H (2007). Differential protein expression in pancreatic islets after treatment with an imidazoline compound. Cell Mol Life Sci. 64(10): 1310-6
Pubmed
IV. Shafqat J, Ishrat M, Jägerbrink T, Sillard R, Mäeorg U, Efendic S, Berggren PO, Zaitsev SV, Jörnvall H (2008). Proteins in the insulin-secreting cell line MIN6 bind the imidazoline compound BL11282. FEBS Lett. 582(11): 1613-7. Epub 2008 Apr 15
Pubmed
V. Naseeb, U, Shafqat J, Jägerbrink T, Zarina S, Alvestrand A, Jörnvall H, Axelsson J (2008). Proteome patterns in uremic plasma. [Submitted]
VI. Jägerbrink T, Lindahl, E, Shafqat J, Jörnvall H (2008). Oxidatively mediated biotinylation of peptide-protein interactions identifies binding of proinsulin C-peptide to phosphotyrosine phosphatase 1B. [Submitted]
I. Hirschberg D, Jägerbrink T, Samskog J, Gustafsson M, Ståhlberg M, Alvelius G, Husman B, Carlquist M, Jörnvall H, Bergman T (2004). Detection of phosphorylated peptides in proteomic analyses using microfluidic compact disk technology. Anal Chem. 76(19): 5864-71
Pubmed
II. Tollin M, Jägerbrink T, Haraldsson A, Agerberth B, Jörnvall H (2006). Proteome analysis of vernix caseosa. Pediatr Res. 60(4): 430-4. Epub 2006 Aug 28
Pubmed
III. Jägerbrink T, Lexander H, Palmberg C, Shafqat J, Sharoyko V, Berggren PO, Efendic S, Zaitsev S, Jörnvall H (2007). Differential protein expression in pancreatic islets after treatment with an imidazoline compound. Cell Mol Life Sci. 64(10): 1310-6
Pubmed
IV. Shafqat J, Ishrat M, Jägerbrink T, Sillard R, Mäeorg U, Efendic S, Berggren PO, Zaitsev SV, Jörnvall H (2008). Proteins in the insulin-secreting cell line MIN6 bind the imidazoline compound BL11282. FEBS Lett. 582(11): 1613-7. Epub 2008 Apr 15
Pubmed
V. Naseeb, U, Shafqat J, Jägerbrink T, Zarina S, Alvestrand A, Jörnvall H, Axelsson J (2008). Proteome patterns in uremic plasma. [Submitted]
VI. Jägerbrink T, Lindahl, E, Shafqat J, Jörnvall H (2008). Oxidatively mediated biotinylation of peptide-protein interactions identifies binding of proinsulin C-peptide to phosphotyrosine phosphatase 1B. [Submitted]
Issue date: 2008-05-23
Rights:
Publication year: 2008
ISBN: 978-91-7409-046-8
Statistics
Total Visits
Views | |
---|---|
Proteomic ...(legacy) | 843 |
Proteomic ... | 99 |
Total Visits Per Month
February 2024 | March 2024 | April 2024 | May 2024 | June 2024 | July 2024 | August 2024 | |
---|---|---|---|---|---|---|---|
Proteomic ... | 0 | 1 | 0 | 0 | 3 | 1 | 1 |
File Visits
Views | |
---|---|
thesis.pdf(legacy) | 578 |
thesis.pdf | 244 |
thesis.pdf.txt(legacy) | 2 |
Top country views
Views | |
---|---|
United States | 373 |
China | 65 |
Germany | 54 |
Sweden | 47 |
South Korea | 18 |
Finland | 16 |
Russia | 16 |
Turkey | 16 |
Denmark | 10 |
United Kingdom | 9 |
Top cities views
Views | |
---|---|
Sunnyvale | 45 |
Romeo | 37 |
Beijing | 23 |
Kiez | 19 |
Seoul | 17 |
Istanbul | 15 |
Nürnberg | 11 |
Helsinki | 10 |
London | 8 |
Stockholm | 8 |